Effects of PI3Kgamma inhibition using AS-605240 in acute myocardial infarction

Circ Res. 2010 Jul 23;107(2):e5; author reply e6-7. doi: 10.1161/CIRCRESAHA.110.224568.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Animals
  • Cardiovascular Agents / pharmacology*
  • Disease Models, Animal
  • Genotype
  • Mice
  • Mice, Knockout
  • Myocardial Infarction / drug therapy*
  • Myocardial Infarction / enzymology
  • Myocardial Infarction / genetics
  • Myocardial Infarction / physiopathology
  • Myocardium / enzymology*
  • Neovascularization, Physiologic / drug effects
  • Phenotype
  • Phosphatidylinositol 3-Kinases / genetics
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphoinositide-3 Kinase Inhibitors*
  • Protein Kinase Inhibitors / pharmacology*
  • Quinoxalines / pharmacology*
  • Thiazolidinediones / pharmacology*
  • Ventricular Function, Left / drug effects
  • Ventricular Remodeling / drug effects

Substances

  • 5-quinoxalin-6-ylmethylenethiazolidine-2,4-dione
  • Cardiovascular Agents
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Kinase Inhibitors
  • Quinoxalines
  • Thiazolidinediones